Does TSH suppression therapy cause tumor progression in differentiated thyroid cancer?
Thyroid-Stimulating Hormone (TSH) suppression therapy is a standard treatment for managing differentiated thyroid cancer (DTC) after surgery. The goal of this therapy is to keep TSH levels low, which helps prevent the cancer from growing or spreading.
What the research says
Research indicates that high levels of TSH can actively promote tumor progression. Specifically, TSH can trigger signaling pathways that lead to the growth, invasion, and dedifferentiation of thyroid cancer cells 2. It can also work with other factors to cause the loss of cell death signals, allowing tumors to grow more easily over time 2.
Because high TSH levels are linked to these harmful effects, suppression therapy is used to control the disease. Clinical reviews have shown that patients receiving TSH suppression therapy have a lower risk of major adverse events, such as disease progression or recurrence, compared to those who do not 6. Additionally, long-term TSH suppression has been noted to reduce the risk of cancer recurrence and help manage the progress of the disease 7.
What to ask your doctor
- How does TSH suppression therapy specifically work to slow my cancer's growth?
- What are the specific goals for my TSH levels during treatment?
- What are the potential side effects of long-term TSH suppression therapy for me?
- How often will we monitor my TSH levels to ensure they remain in the target range?
This question is drawn from common patient questions about Oncology and answered using cited medical research. We do not provide individualized advice.